Not applicableUnknownNCT01927133What this trial is testingLIVER FIBROSIS PREVALENCE IN FRANCEWho this might be right forLiver Fibrosis Progression in Chronic Liver Disease Assistance Publique - Hôpitaux de Paris 10,000
Not applicableActive Not RecruitingNCT06304467What this trial is testingCM for Patients With ALD After Liver TransplantWho this might be right forAlcohol Use DisorderAlcohol; LiverPost Liver Transplant+2 more Arpan A. Patel, MD 30
Large-scale testing (Phase 3)Looking for participantsNCT06461208What this trial is testingA PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With CirrhosisWho this might be right forLiver Cirrhosis King's College London 300
Not applicableLooking for participantsNCT05699018What this trial is testingScreening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic PatientsWho this might be right forNon-alcoholic Fatty Liver Disease (NAFLD)Alcoholic Liver Disease (ALD)Liver Fibrosis University Hospital, Angers 1,788
Not applicableLooking for participantsNCT05385237What this trial is testingIdentification of Hepatic Fibrosis Using 4D-MRIWho this might be right forLiver Diseases University Hospital, Basel, Switzerland 200
Not applicableLooking for participantsNCT07169526What this trial is testingHealth Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver CirrhosisWho this might be right forSelf-EfficacyHealth LiteracyLiver Cirrhosis+1 more Hannover Medical School 200
Not applicableLooking for participantsNCT03224949What this trial is testingComparison of ALD, NASH, and Healthy Control PatientsWho this might be right forALD - Alcoholic Liver Disease The Cleveland Clinic 500
Not applicableActive Not RecruitingNCT03113929What this trial is testingQuantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)Who this might be right forAlcoholic Liver Disease The Cleveland Clinic 20
Testing effectiveness (Phase 2)Looking for participantsNCT06613698What this trial is testingInvestigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver DiseaseWho this might be right forLiver Diseases, Alcoholic GlaxoSmithKline 393
Large-scale testing (Phase 3)Study completedNCT02200029What this trial is testingStudy With Heptral in Subjects With Liver Disease Due to Alcohol ConsumptionWho this might be right forIntrahepatic Cholestasis Associated With Alcoholic Liver Disease Abbott 75
Large-scale testing (Phase 3)Looking for participantsNCT07428538What this trial is testingStudy to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)Who this might be right forHepatitis Bausch Health Americas, Inc. 350
Not applicableLooking for participantsNCT03308916What this trial is testingScreening At-risk Populations for Hepatic Fibrosis With Non-invasive MarkersWho this might be right forLiver Diseases, AlcoholicFibrosis Maja Thiele 6,500
Large-scale testing (Phase 3)Study completedNCT00573313What this trial is testingEffects of SAMe in Patients With Alcoholic Liver DiseaseWho this might be right forLiver Disease, Alcoholic University of California, Davis 94
Not applicableNot Yet RecruitingNCT06907563What this trial is testingLong-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)Who this might be right forSteatotic Liver DiseaseMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Steatotic Liver Disease of Mixed Origin (MetALD)+1 more Universität des Saarlandes 30,000